Evidence map›Paper›PMID 30207784›Full record

ArticleAmerican journal of physiology. Cell physiology2018

Skeletal muscle atrophy and dysfunction in breast cancer patients: role for chemotherapy-derived oxidant stress.

Blas A Guigni, Damien M Callahan, Timothy W Tourville, Mark S Miller, Brad Fiske, Thomas Voigt, Bethany Korwin-Mihavics, Vikas Anathy, Kim Dittus, Michael J Toth

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05684367 narecruitingnot on this mapstarted 2023, after this paper: background citation

Center-Based and Home-Based Walking Exercise Intervention to Reduce Fatigue in Older Breast Cancer Survivors

TypeinterventionalSponsorUniversity of FloridaRan2023 to 2026Enrolled24ConditionsFatigue, Breast Cancer, Cancer, Therapy-RelatedArmsCenter-Based Walking Exercise, Home-Based Walking Exercise
NCT07484776 naactive not recruitingnot on this mapstarted 2026, after this paper: background citation

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer and the Possible Effect of a Physical Exercise Intervention

TypeinterventionalSponsorUniversidad Europea de MadridRan2026 to 2028Enrolled40ConditionsTriple-Negative Breast Cancer (TNBC)ArmsCardiovascular training at maximal fat oxidation (FATmax), Cardiovascular training at maximal aerobic power (MAP), Resistance training
3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Blas A GuigniDepartment of Medicine, College of Medicine, University of Vermont , Burlington, Vermont.ORCID 0000-0002-9667-8195
Damien M CallahanDepartment of Medicine, College of Medicine, University of Vermont , Burlington, Vermont.
Timothy W TourvilleDepartment of Orthopedics and Rehabilitation, College of Medicine, University of Vermont , Burlington, Vermont.
Mark S MillerDepartment of Kinesiology, University of Massachusetts Amherst , Amherst, Massachusetts.
Brad FiskeDepartment of Medicine, College of Medicine, University of Vermont , Burlington, Vermont.
Thomas VoigtDepartment of Medicine, College of Medicine, University of Vermont , Burlington, Vermont.
Bethany Korwin-MihavicsDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Vermont , Burlington, Vermont.
Vikas AnathyDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Vermont , Burlington, Vermont.
Kim DittusDepartment of Medicine, College of Medicine, University of Vermont , Burlington, Vermont.
Michael J TothDepartment of Medicine, College of Medicine, University of Vermont , Burlington, Vermont.
University of Vermont · USUniversity of Massachusetts Amherst · US

Funding

Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI KHADANGA, SHERRIE · 2013 to 2022
$21.3M
VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HILL, JACK · 2006 to 2011
$14.5M
Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
Skeletal Muscle Atrophy and Dysfunction in Human CancerR01AR065826 · NIAMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TOTH, MICHAEL J · 2016 to 2021
$2.1M
Alternative exercise modalities to improve skeletal muscle function in cancer survivorsR21CA191532 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TOTH, MICHAEL J · 2016 to 2017
$371k
NCI NIH HHS R21 CA191532NCRR NIH HHS P20 RR021905NIAMS NIH HHS R01 AR065826NIGMS NIH HHS P20 GM103644NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

How breast cancer and its treatments affect skeletal muscle is not well defined. To address this question, we assessed skeletal muscle structure and protein expression in 13 women who were diagnosed with breast cancer and receiving adjuvant chemotherapy following tumor resection and 12 nondiseased controls. Breast cancer patients showed reduced single-muscle fiber cross-sectional area and fractional content of subsarcolemmal and intermyofibrillar mitochondria. Drugs commonly used in breast cancer patients (doxorubicin and paclitaxel) caused reductions in myosin expression, mitochondrial loss, and increased reactive oxygen species (ROS) production in C2C12 murine myotube cell cultures, supporting a role for chemotherapeutics in the atrophic and mitochondrial phenotypes. Additionally, concurrent treatment of myotubes with the mitochondrial-targeted antioxidant MitoQ prevented chemotherapy-induced myosin depletion, mitochondrial loss, and ROS production. In patients, reduced mitochondrial content and size and increased expression and oxidation of peroxiredoxin 3, a mitochondrial peroxidase, were associated with reduced muscle fiber cross-sectional area. Our results suggest that chemotherapeutics may adversely affect skeletal muscle in patients and that these effects may be driven through effects of these drugs on mitochondrial content and/or ROS production.

Indexed as

AgedAnimalsAntineoplastic AgentsBreast NeoplasmsCachexiaFemaleGene Expression Regulation, NeoplasticHumansMiceMiddle AgedMuscle, SkeletalMuscular AtrophyMyosinsOrganophosphorus CompoundsOxidative StressPeroxiredoxin IIIAntineoplastic AgentsmitoquinoneMyosinsOrganophosphorus CompoundsPeroxiredoxin IIIPRDX3 protein, humanReactive Oxygen SpeciesUbiquinonecachexiamitochondriamyotube

Identifiers

PMID30207784
PMCPMC6293050
OpenAlexW2890169690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.